GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028

Lifesciences | Healthcare IT

GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028

Market by Phase Type, Service, Sponsor, and Regional Outlook | Forecast 2022-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Services that aid in optimizing the process of conducting clinical trials are known as clinical trial support services. Support services help speed up the trial process by managing data and analyzing it. There is a rise in the prevalence of infectious and tropical diseases, especially in developing nations. The numerous unmet needs of patients call for the development of novel drugs for disease treatment, which necessitates carrying out clinical trials. Also, the exposure to new diseases like COVID-19 and monkeypox has increased the demand for vaccines. All of these requirements have created opportunities for businesses to provide support services in order to maintain the massive amounts of data.

According to Triton Market Research’s report, the Global Clinical Trials Support Services Market is likely to reach $34994.75 million by 2028, from $20677.01 million in 2021, with a CAGR of 7.84% during the forecast period 2022-2028.


Click here to check out our blog on the Global Clinical Trials Support Services Market

MARKET PERFORMANCE: DRIVERS, CHALLENGES, AND TRENDS

Over the forecast period, the market expansion is likely to be fueled by the rising disease incidence and the effectiveness of support services in overcoming the barriers encountered while conducting clinical trials. For instance, the costs associated with conducting clinical trials are increasing, which has become a significant challenge. Other difficulties associated with performing clinical trials include complexity, time required, and risk management. Contract research organizations (CROs) have developed a variety of solutions to address these issues in order to make the process more effective and worthwhile. These solutions include site selection & recruitment, clinical trial site management, data management, and others.

However, the disadvantages of open-source software and delays in receiving approvals due to stringent regulatory frameworks are factors hindering the market growth. Clinical trials are a crucial step in the development of new medical products. And before initiating these trials for a larger patient population, it is necessary to seek approval from regulatory bodies. The guidelines issued by regulatory authorities demand that medical products are efficient and safe for human consumption, among other requirements. Sometimes, ensuring that companies and research institutions meet all the requirements consumes a significant amount of time-intensive. This delays the approval of clinical trials, thus impacting the entire process of testing the medical product.

The rise in screening tests presents an overall positive outlook for the market. The number of patients has increased over time. For instance, globally, prevalent cases of total cardiovascular diseases nearly doubled, from 271 million in 1990 to 523 million in 2019. As a result, the need for developing effective treatments also increased. The number of clinical trials conducted has also increased due to this, which has led to more screening tests being performed prior to including patients in trials. The use of screening tests to determine whether prospective subjects are suitable candidates for inclusion in trials is an appropriate pre-entry activity for some studies.




KEY GEOGRAPHIES COVERED:

•         North America: United States and Canada

•         Europe: United Kingdom, France, Germany, Spain, Italy, and Rest of Europe

•         Asia-Pacific: China, Japan, India, Australia, New Zealand, South Korea, ASEAN Countries, and Rest of Asia Pacific

•         Latin America: Brazil, Mexico, and Rest of Latin America

•         Middle East and Africa: Saudi Arabia, Turkey, United Arab Emirates, South Africa, and Rest of Middle East & Africa


SEGMENTATION ANALYSIS – CLINICAL TRIALS SUPPORT SERVICES MARKET:

•         Market by Phase Type:

o        Phase I

o        Phase II

o        Phase III

o        Phase IV

Phase I is expected to be the fastest-growing phase type, with a CAGR of 9.32%. Clinical trials begin with a phase I trial, which verifies that they are safe to conduct on people. This phase assesses the distribution of the drug or vaccine throughout the body. Only a small group of healthy people participate voluntarily. The study’s initial participants receive a very small dose of the medication and are closely monitored. The subsequent participants will receive a dose that is higher if there are only minor side effects.

 

•         Market by Service:

o        Clinical Trial Site Management

o        Administrative Staff

o        Patient Recruitment Management

o        Institutional Review Board (IRB)

o        Data Management

o        Other Services

Clinical trial site management is the largest service, which accounted for the highest revenue share of $9124.68 million in 2021. Conducting a clinical trial is a massive and difficult task. A clinical trial necessitates the participation of thousands, if not millions, of people – patients, doctors, researchers, and so on. It also entails collecting a large amount of data that must be stored and secured. This data is critical and must be kept up to date on a regular basis. Also, such sensitive data cannot be handled manually, which is where clinical trial management software comes in. Because of advances in technology, the process of conducting clinical trials has become more streamlined.

 

•         Market by Sponsor:

o        Pharmaceutical & Biopharmaceutical Companies

o        Medical Device Companies

o        Other Sponsors

 

COMPETITIVE LANDSCAPE:

The competitive landscape helps dive into data about the key players in the clinical trials support services market. The strategic initiatives for each of the companies considered have been covered in detail.

Acquisition (February 2021): ICON Plc and PRA Health Sciences

PRA Health Sciences, a contract research organization that develops drugs and provides clinical development services, was acquired by ICON Plc.

Investments & Expansions (February 2021): KCR

KCR established a new branch in Sydney, Australia. The new location will widen KCR’s regional coverage while also increasing clinical capabilities for clients worldwide.

 

KEY BENEFITS OF THE REPORT:

·       Triton Market Research has a collective experience of 25-30 years in the industry, with its analysts and experts encompassing the most infallible research methodology for its market intelligence and industry analysis.

·       Our research methodology helps in achieving a broader consensus of the market size, shape, and industry trends within each industry segment.

·       The strategy adopted in designing the research methodology includes the amalgamation of the information assembled from primary and secondary sources, with the assistance of analytical tools to construct the forecast and predictive models.

·       The scope of the market report comprises the current scenario of the global clinical trials support services market, along with the detailed overview of the industry outlook, market dynamics, segmentation analysis, regional outlook, and competitive landscape for the period 2022-2028.

 

FAQs:

Q 1) Does this report include the impact of COVID-19 on the clinical trials support services market?

The market study has analyzed the impact of COVID-19 on the clinical trial support services market qualitatively as well as quantitatively.

Q 2) Which region held the largest market share in 2021?

The majority of the market share was held by North America in 2021, with $8200.15 million in revenue.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET

2.2. KEY INSIGHTS

2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS

2.2.2. INCREASE IN SCREENING TESTS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. KEY BUYING IMPACT ANALYSIS

2.4.1. PERFORMANCE

2.4.2. EASE OF USE

2.4.3. SECURITY

2.4.4. COST EFFECTIVENESS

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.8. REGULATORY FRAMEWORK

2.9. KEY MARKET STRATEGIES

2.9.1. ACQUISITIONS

2.9.2. PRODUCT LAUNCHES

2.9.3. CONTRACTS & AGREEMENTS

2.9.4. INVESTMENTS & EXPANSIONS

2.10. MARKET DRIVERS

2.10.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS

2.10.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE

2.11. MARKET CHALLENGES

2.11.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK

2.11.2. USE OF OPEN-SOURCE SOFTWARE

2.12. MARKET OPPORTUNITIES

2.12.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS

2.12.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH

2.12.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET

3. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE

3.1. PHASE I

3.2. PHASE II

3.3. PHASE III

3.4. PHASE IV

4. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE

4.1. CLINICAL TRIAL SITE MANAGEMENT

4.2. ADMINISTRATIVE SERVICES

4.3. PATIENT RECRUITMENT MANAGEMENT

4.4. REGULATORY SERVICES

4.5. DATA MANAGEMENT

4.6. OTHER SERVICES

5. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR

5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES

5.2. MEDICAL DEVICE COMPANIES

5.3. OTHER SPONSORS

6. GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET – REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1. MARKET OUTLOOK BY SERVICE

6.1.2. MARKET OUTLOOK BY PHASE TYPE

6.1.3. MARKET OUTLOOK BY SPONSOR

6.1.4. COUNTRY ANALYSIS

6.1.4.1. UNITED STATES

6.1.4.2. CANADA

6.2. EUROPE

6.2.1. MARKET OUTLOOK BY SERVICE

6.2.2. MARKET OUTLOOK BY PHASE TYPE

6.2.3. MARKET OUTLOOK BY SPONSOR

6.2.4. COUNTRY ANALYSIS

6.2.4.1. UNITED KINGDOM

6.2.4.2. GERMANY

6.2.4.3. FRANCE

6.2.4.4. SPAIN

6.2.4.5. ITALY

6.2.4.6. REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1. MARKET OUTLOOK BY SERVICE

6.3.2. MARKET OUTLOOK BY PHASE TYPE

6.3.3. MARKET OUTLOOK BY SPONSOR

6.3.4. COUNTRY ANALYSIS

6.3.4.1. CHINA

6.3.4.2. JAPAN

6.3.4.3. INDIA

6.3.4.4. SOUTH KOREA

6.3.4.5. ASEAN COUNTRIES

6.3.4.6. AUSTRALIA & NEW ZEALAND

6.3.4.7. REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1. MARKET OUTLOOK BY SERVICE

6.4.2. MARKET OUTLOOK BY PHASE TYPE

6.4.3. MARKET OUTLOOK BY SPONSOR

6.4.4. COUNTRY ANALYSIS

6.4.4.1. BRAZIL

6.4.4.2. MEXICO

6.4.4.3. REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1. MARKET OUTLOOK BY SERVICE

6.5.2. MARKET OUTLOOK BY PHASE TYPE

6.5.3. MARKET OUTLOOK BY SPONSOR

6.5.4. COUNTRY ANALYSIS

6.5.4.1. UNITED ARAB EMIRATES

6.5.4.2. SAUDI ARABIA

6.5.4.3. TURKEY

6.5.4.4. SOUTH AFRICA

6.5.4.5. REST OF MIDDLE EAST & AFRICA

7. COMPETITIVE LANDSCAPE

7.1. IQVIA

7.2. PAREXEL

7.3. ICON PLC

7.4. SYNEOS HEALTH

7.5. LABCORP DRUG DEVELOPMENT

7.6. CLINIPACE

7.7. KCR

7.8. CHARLES RIVER LABORATORIES

7.9. MEDPACE

7.10. ALCURA

7.11. PSI CRO

7.12. WORLDWIDE CLINICAL TRIALS

7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC

7.14. WUXI APPTEC

7.15. ADVANCED CLINICAL

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 2: LIST OF COLLABORATIONS

TABLE 3: VENDOR SCORECARD

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: LIST OF ACQUISITIONS

TABLE 6: LIST OF PRODUCT LAUNCHES

TABLE 7: LIST OF CONTRACTS & AGREEMENTS

TABLE 8: LIST OF INVESTMENTS & BUSINESS EXPANSIONS

TABLE 9: LIST OF PANDEMIC OUTBREAKS

TABLE 10: LIST OF OPEN-SOURCE SOFTWARE

TABLE 11: LAUNCH OF MEDICAL DRUGS

TABLE 12: PROMISING ACQUISITIONS IN THE MARKET

TABLE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)

TABLE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)

TABLE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 17: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)

TABLE 18: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 19: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)

TABLE 20: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 21: NUMBER AND TYPES OF REGISTERED STUDIES

TABLE 22: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)

TABLE 23: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)

TABLE 25: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 26: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)

TABLE 27: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 28: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)

TABLE 29: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 30: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)

TABLE 31: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 32: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)

TABLE 33: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 34: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)

TABLE 35: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 36: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)

TABLE 37: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

List of Figures

FIGURE 1: KEY BUYING IMPACT ANALYSIS

FIGURE 2: MARKET ATTRACTIVENESS INDEX

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)

FIGURE 5: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)

FIGURE 6: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)

FIGURE 7: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)

FIGURE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)

FIGURE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)

FIGURE 10: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)

FIGURE 11: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)

FIGURE 12: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)

FIGURE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)

FIGURE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)

FIGURE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)

FIGURE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)

FIGURE 17: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)

FIGURE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)

FIGURE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)

FIGURE 20: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)

FIGURE 21: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 22: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 23: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 25: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 26: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 27: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 28: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 29: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 30: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 31: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 32: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 33: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 34: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 35: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 36: ASEAN COUNTRIES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 37: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 38: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 39: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 40: BRAZIL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 41: MEXICO CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 42: REST OF LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 43: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 44: UNITED ARAB EMIRATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 45: SAUDI ARABIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 46: TURKEY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 47: SOUTH AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 48: REST OF MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;